Cardioprotective effect of propofol against oxygen glucose deprivation and reperfusion injury in H9c2 cells

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Zhao, Dandan ^a   Li, Qing ^a   Huang, Qiuping ^a   Li, Xuguang ^a   Yin, Min ^a   Wang, Zejian ^a   Hong, Jiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETICS; CELL CULTURE; CYTOLOGY; GLUCOSE; OXYGEN;

ANTIOXIDATIVE EFFECTS; CARDIOPROTECTIVE EFFECT; DOSE-DEPENDENT MANNER; ISCHEMIA-REPERFUSION INJURY; LACTATE DEHYDROGENASE; OXYGEN GLUCOSE DEPRIVATION; REACTIVE OXYGEN SPECIES; SUPER OXIDE DISMUTASE;

CELLS;

CATALASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROPOFOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; GLUCOSE; NERVE PROTEIN; OXYGEN; PROTECTIVE AGENT;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; H9C2 CELL LINE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; OXYGEN GLUCOSE DEPRIVATION; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ANIMAL; APOPTOSIS; CELL LINE; DRUG EFFECTS; METABOLISM;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CATALASE; CELL LINE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; L-LACTATE DEHYDROGENASE; MALONDIALDEHYDE; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; OXYGEN; PROPOFOL; PROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84925324922     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/184938     Document Type: Article

References (52)

1. A. S. Go, D. Mozaffarian, V. L. Roger et al., "Heart disease and stroke statistics-2013 update: a report from the American Heart Association," Circulation, vol. 127, no. 1, pp. e6-e245, 2013.
2. B. Halliwell, "Antioxidant characterization. Methodology and mechanism," Biochemical Pharmacology, vol. 49, no. 10, pp. 1341-1348, 1995.
3. N. Singh, A. K. Dhalla, C. Seneviratne, and P. K. Singal, "Oxidative stress and heart failure," Molecular and Cellular Biochemistry, vol. 147, no. 1-2, pp. 77-81, 1995.
4. A. Ramond, D. Godin-Ribuot, C. Ribuot et al., "Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia," Fundamental & Clinical Pharmacology, vol. 27, no. 3, pp. 252-261, 2013.
5. E.-M. Jeong, M. Liu, M. Sturdy et al., "Metabolic stress, reactive oxygen species, and arrhythmia," Journal of Molecular and Cellular Cardiology, vol. 52, no. 2, pp. 454-463, 2012.
6. J. Wahr, J. Vender, H. C. Gilbert, B. Spiess, J. C. Horrow, and R. Maddi, "Effect of propofol with and without EDTA on haemodynamics and calcium and magnesium homeostasis during and after cardiac surgery," Intensive Care Medicine, vol. 26, supplement 4, pp. S443-S451, 2000.
7. I. Vasileiou, T. Xanthos, E. Koudouna et al., "Propofol: a review of its non-anaesthetic effects," European Journal of Pharmacology, vol. 605, no. 1-3, pp. 1-8, 2009.
8. Q. Liu, A.-L. Kong, R. Chen et al., "Propofol and arrhythmias: two sides of the coin," Acta Pharmacologica Sinica, vol. 32, no. 6, pp. 817-823, 2011.
9. Q. Liu, J.-Y. Yao, C. Qian et al., "Effects of propofol on ischemiainduced ventricular arrhythmias and mitochondrial ATPsensitive potassium channels," Acta Pharmacologica Sinica, vol. 33, no. 12, pp. 1495-1501, 2012.
10. P. Hans, G. Deby-Dupont, C. Deby et al., "Increase in antioxidant capacity of plasma during propofol anesthesia," Journal of Neurosurgical Anesthesiology, vol. 9, no. 3, pp. 234-236, 1997.
11. W. Li, Y. Zhang, Y. Liu et al., "In vitro kinetic evaluation of the free radical scavenging ability of propofol," Anesthesiology, vol. 116, no. 6, pp. 1258-1266, 2012.
12. 2t- isoprostane formation and tissue antioxidant capacity," Cardiovascular Research, vol. 59, no. 1, pp. 113-121, 2003.
13. B. J. McDermott, S. McWilliams, K. Smyth et al., "Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity," Journal of Molecular and Cellular Cardiology, vol. 42, no. 3, pp. 600-608, 2007.
14. S. A. Javadov, K. H. H. Lim, P. M. Kerr, M.-S. Suleiman, G. D. Angelini, and A. P. Halestrap, "Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition," Cardiovascular Research, vol. 45, no. 2, pp. 360-369, 2000.
15. Y. C. Jin, W. Kim, Y. M. Ha et al., "Propofol limits ratmyocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo," Vascular Pharmacology, vol. 50, no. 1-2, pp. 71-77, 2009.
16. A. Sengupta, V. V. Kalinichenko, and K. E. Yutzey, "FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation," Circulation Research, vol. 112, no. 2, pp. 267-277, 2013.
17. E. L. Greer and A. Brunet, "FOXO transcription factors at the interface between longevity and tumor suppression," Oncogene, vol. 24, no. 50, pp. 7410-7425, 2005.
18. K. Inoki, J. Kim, and K.-L. Guan, "AMPK and mTOR in cellular energy homeostasis and drug targets," Annual Review of Pharmacology and Toxicology, vol. 52, pp. 381-400, 2012.
19. M. A. Paiva, L. M. Gonçalves, L. A. Providência, S. M. Davidson, D. M. Yellon, and M. M. Mocanu, "Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction," Cardiovascular Drugs and Therapy, vol. 24, no. 1, pp. 25-32, 2010.
20. S. Lee, K. Kim, Y. H. Kim et al., "Preventive role of propofol in hypoxia/reoxygenation-induced apoptotic H9c2 rat cardiac myoblast cell death," Molecular Medicine Reports, vol. 4, no. 2, pp. 351-356, 2011.
21. J. L. Martindale and N. J. Holbrook, "Cellular response to oxidative stress: signaling for suicide and survival," Journal of Cellular Physiology, vol. 192, no. 1, pp. 1-15, 2002.
22. T. A. Rodrigues, R. A. Alexandrino, M. E. Kanczuk, J. L. Gozzani, and L. A. D. S. T. Mathias, "A comparative study of non-lipid nanoemulsion of propofol with solutol and propofol emulsion with lecithin," Revista Brasileira de Anestesiologia, vol. 62, no. 3, pp. 325-334, 2012.
23. L. G. Kevin, E. Novalija, and D. F. Stowe, "Reactive oxygen species is mediators of cardiac injury and protection: the relevance to anesthesia practice," Anesthesia and Analgesia, vol. 101, no. 5, pp. 1275-1287, 2005.
24. M. A. Arstall, J. Yang, I. Stafford, W. H. Betts, and J. D. Horowitz, "N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects," Circulation, vol. 92, no. 10, pp. 2855-2862, 1995.
25. B. Wang, J. Shravah, H. Luo, K. Raedschelders, D. D. Y. Chen, and D. M. Ansley, "Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells viaAkt activation and Bcl-2 up-regulation," Biochemical and Biophysical Research Communications, vol. 389, no. 1, pp. 105-111, 2009.
26. L. B. Becker, "New concepts in reactive oxygen species and cardiovascular reperfusion physiology," Cardiovascular Research, vol. 61, no. 3, pp. 461-470, 2004.
27. S. V. V. Lakshmi, G. Padmaja, P. Kuppusamy, and V. K. Kutala, "Oxidative stress in cardiovascular disease," Indian Journal of Biochemistry and Biophysics, vol. 46, no. 6, pp. 421-440, 2009.
28. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
29. F. Nielsen, B. B. Mikkelsen, J. B. Nielsen, H. R. Andersen, and P. Grandjean, "Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors," Clinical Chemistry, vol. 43, no. 7, pp. 1209-1214, 1997.
30. J. M. Matés, "Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology," Toxicology, vol. 153, no. 1-3, pp. 83-104, 2000.
31. K. Vijayasarathy, K. Shanthi Naidu, and B. K. S. Sastry, "Melatonin metabolite 6-Sulfatoxymelatonin, Cu/Zn superoxide dismutase, oxidized LDL and malondialdehyde in unstable angina," International Journal of Cardiology, vol. 144, no. 2, pp. 315-317, 2010.
32. I. Fridovich, "Superoxide radical and superoxide dismutases," Annual Review of Biochemistry, vol. 64, pp. 97-112, 1995.
33. S. L. Marklund, "Human copper-containing superoxide dismutase of high molecular weight," Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 24, pp. 7634-7638, 1982.
34. J. I. Harris, A. D. Auffret, F. D. Northrop, and J. E. Walker, "Structural comparisons of superoxide dismutases," FEBS, vol. 106, no. 1, pp. 297-303, 1980.
35. M. Tanaka, G. K. Mokhtari, R. D. Terry et al., "Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts," Circulation, vol. 110, no. 11, pp. II200-II206, 2004.
36. M. Giorgio, M. Trinei, E. Migliaccio, and P. G. Pelicci, "Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?" Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 722-728, 2007.
37. H. Huang and D. J. Tindall, "Dynamic FoxO transcription factors," Journal of Cell Science, vol. 120, no. 15, pp. 2479-2487, 2007.
38. D. A. Salih and A. Brunet, "FoxO transcription factors in the maintenance of cellular homeostasis during aging," Current Opinion in Cell Biology, vol. 20, no. 2, pp. 126-136, 2008.
39. M. C. W. van den Berg and B. M. T. Burgering, "Integrating opposing signals toward forkhead box O," Antioxidants and Redox Signaling, vol. 14, no. 4, pp. 607-621, 2011.
40. K. N. Papanicolaou, Y. Izumiya, and K. Walsh, "Forkhead transcription factors and cardiovascular biology," Circulation Research, vol. 102, no. 1, pp. 16-31, 2008.
41. M. Aoki, H. Jiang, and P. K. Vogt, "Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 37, pp. 13613-13617, 2004.
42. A. R. Subauste and C. F. Burant, "Role of FoxO1 in FFAinduced oxidative stress in adipocytes," The American Journal of Physiology-Endocrinology and Metabolism, vol. 293, no. 1, pp. E159-E164, 2007.
43. N. R. Sundaresan, S. A. Samant, V. B. Pillai, S. B. Rajamohan, and M. P. Gupta, "SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70," Molecular and Cellular Biology, vol. 28, no. 20, pp. 6384-6401, 2008.
44. E. L. Greer, P. R. Oskoui, M. R. Banko et al., "The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor," The Journal of Biological Chemistry, vol. 282, no. 41, pp. 30107-30119, 2007.
45. X.-N. Li, J. Song, L. Zhang et al., "Activation of the AMPKFOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin," Diabetes, vol. 58, no. 10, pp. 2246-2257, 2009.
46. ′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase," Journal of Biological Chemistry, vol. 270, no. 29, pp. 17513-17520, 1995.
47. J. R. B. Dyck and G. D. Lopaschuk, "AMPK alterations in cardiac physiology and pathology: enemy or ally?" The Journal of Physiology, vol. 574, no. 1, pp. 95-112, 2006.
48. ′- monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart," Cardiovascular Drugs and Therapy, vol. 26, no. 6, pp. 467-478, 2012.
49. S. Asada, H. Daitoku, H. Matsuzaki et al., "Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1," Cellular Signalling, vol. 19, no. 3, pp. 519-527, 2007.
50. H. Kurokawa, P. A. Murray, and D. S. Damron, "Propofol attenuates β-adrenoreceptor-mediated signal transduction via a protein kinase C-dependent pathway in cardiomyocytes," Anesthesiology, vol. 96, no. 3, pp. 688-698, 2002.
51. Y. Zhang, Y. Dong, Z. Xu, and Z. Xie, "Propofol andmagnesium attenuate isoflurane-induced caspase-3 activation via inhibiting mitochondrial permeability transition pore," Medical Gas Research, vol. 2, article 20, 2012.
52. Y. Li, Y. J. Liu, G. Lv, D. L. Zhang, L. Zhang, and D. Li, "Propofol protects against hydrogen peroxide-induced apoptosis in cardiac H9c2 cells is associated with the NF-kappaB activation and PUMAexpression," European Review for Medical and Pharmacological Sciences, vol. 18, pp. 1517-1524, 2014.